European Markets for Drug Eluting and Bare Metal Stents (15 Countries)

Summary

The European market, as defined in this report, encompasses Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands, and Luxemburg), Scandinavia (Finland, Denmark, Sweden, and Norway), Portugal, Austria, and Switzerland. Additional products included in this report: Bioabsorbable Stents, Bifurcated Stentsand bare-metal stents.

Contents

• European Markets For Drug-Eluting And Bare Metal Stents 2009 (15 Countries)
• Idata_Eudes09_Rpti
• List Of Figures
• List Of Charts
• Research Methodology
  • 1.1 Research Scope
  • 1.2 Idata's 9-Step Methodology
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems And Perform Secondary Research
    • Step 3: Preparation For Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast And Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review And Market Release
    • Step 9: Customer Feedback And Market Monitoring
• 2. European Market For Interventional Cardiology Devices
  • 2.1 Introduction
  • 2.2 Currency Exchange Rates
  • 2.3 Effects Of The Economic Crisis
  • 2.4 Overview Of The Market
    • 2.4.1 Market Segmentation By Device Type
    • 2.4.2 Market Segmentation By Country
      • 2.4.2.1 Germany
      • 2.4.2.2 France
      • 2.4.2.3 Italy
      • 2.4.2.4 Spain
      • 2.4.2.5 United Kingdom
      • 2.4.2.6 Benelux
  • 2.5 Trend Analysis By Country
  • 2.6 Market Drivers
  • 2.7 Market Limiters
  • 2.8 Competitive Analysis
  • 2.9 Mergers And Acquisitions
• 3. Country Profiles
  • 3.1 Introduction
    • 3.1.1 Population
    • 3.1.2 Gdp Per Capita
    • 3.1.3 Pci And Des Penetration Rates
    • 3.1.4 Price Index
  • 3.2 Germany
  • 3.3 France
  • 3.4 United Kingdom
  • 3.5 Italy
  • 3.6 Spain
  • 3.7 Benelux
  • 3.8 Scandinavia
  • 3.9 Portugal
  • 3.10 Austria
  • 3.11 Switzerland
• 4. Bare-Metal And Drug-Eluting Stents
  • 4.1 Introduction
  • 4.2 Overview Of The Market
    • 4.2.1 Total Coronary Stent Market
    • 4.2.2 Bare-Metal Versus Drug-Eluting Stents
  • 4.3 Market Analysis And Forecast
    • 4.3.1 Bare-Metal Stent Market
      • 4.3.1.1 Market Analysis And Forecast
      • 4.3.1.2 Bare-Metal Stent Market Drivers
      • 4.3.1.3 Bare-Metal Stent Market Limiters
      • 4.3.1.4 Bare-Metal Stent Competitive Analysis
    • 4.3.2 Drug-Eluting Stent Market
      • 4.3.2.1 Market Analysis And Forecast
      • 4.3.2.2 Drug-Eluting Stent Market Drivers
      • 4.3.2.3 Drug-Eluting Stent Market Limiters
      • 4.3.2.4 Drug-Eluting Stent Competitive Analysis
    • 4.3.3 Stents In Development
      • 4.3.3.1 Bioabsorbable Stents
      • 4.3.3.2 Bifurcated Stents
        • Abbreviations
• List Of Figures
  • Research Methodology
  • European Market For Interventional Cardiology Devices
    • Figure 3-1: Exchange Rates For The Euro (, 2008
    • Figure 3-2: Market For Interventional Cardiology, Europe, 2005 - 2015
    • Figure 3-3: Market For Interventional Cardiology, Segmented By Device Type, Europe, 2005 - 2015 (
    • Figure 3-4: Market For Interventional Cardiology, Segmented By Device Type, Europe, 2005 - 2015 (Us$)
    • Figure 3-5: Market For Interventional Cardiology, Segmented By Country, Europe, 2005 - 2015 (
    • Figure 3-6: Market For Interventional Cardiology, Segmented By Country, Europe, 2005 - 2015 (Us$)
    • Figure 3-7: Interventional Cardiology Market Growth Rates By Country, Europe, 2005 - 2015
    • Figure 3-8: Market Drivers, European Market For Interventional Cardiology, 200841
    • Figure 3-9: Market Limiters, European Market For Interventional Cardiology, 2008
    • Figure 3-10: Leading Competitors, Market For Interventional Cardiology, Europe, 2008
    • Figure 3-11: Leading Competitors, Market For Interventional Cardiology By Country, Europe, 2008 (Part 1)
  • Country Profiles
    • Figure 5-1: Country Indicators, 2008
  • Bare-Metal And Drug-Eluting Stents
    • Figure 6-1: Market For Coronary Stents By Type, Europe, 2005 - 2015 (
    • Figure 6-2: Market For Coronary Stents By Type, Europe, 2005 - 2015 (Us$)
    • Figure 6-3: Market For Coronary Stents By Country, Europe, 2005 - 2015 (
    • Figure 6-4: Market For Coronary Stents By Country, Europe, 2005 - 2015 (Us$)
    • Figure 6-5: Penetration Rate For Coronary Stents By Type, Units Sold, Europe, 2005 - 2015
    • Figure 6-6: Des Penetration By Country, Europe, 2005 - 2015
    • Figure 6-7: Market For Bare-Metal Stents By Country, Europe, 2005 - 2015 (
    • Figure 6-8: Market For Bare-Metal Stents By Country, Europe, 2005 - 2015 (Us$)76
    • Figure 6-9: Market Drivers And Limiters, Market For Bare-Metal Stents, Europe, 2008
    • Figure 6-10: Leading Competitors, Market For Bare-Metal Stents, Europe, 2008
    • Figure 6-11: Market For Drug-Eluting Stents By Country, Europe, 2005 - 2015 (84
    • Figure 6-12: Market For Drug-Eluting Stents By Country, Europe, 2005 - 2015 (Us$)
    • Figure 6-13: Market Drivers And Limiters, Market For Drug-Eluting Stents, Europe, 2008
    • Figure 6-14: Leading Competitors, Market For Drug-Eluting Stents, Europe, 200892
    • Figure 6-15: Coronary Stent Platforms In Development, 2008
    • Figure 6-16: Potential Market For Bioabsorbable Stents, Europe, 2010 - 2015 (
    • Figure 6-17: Potential Market For Bioabsorbable Stents, Europe, 2010 - 2015 (Us$)
    • Figure 6-18: Potential Market For Bifurcated Stents, Europe, 2010 - 2015 (
    • Figure 6-19: Potential Market For Bifurcated Stents, Europe, 2010 - 2015 (Us$)
  • Abbreviations
• List Of Charts
  • Research Methodology
  • European Market For Interventional Cardiology Devices
    • Chart 3-1: Market For Interventional Cardiology, Europe, 2005 - 2015 (
    • Chart 3-2: Market For Interventional Cardiology, Segmented By Device Type, Europe, 2008
    • Chart 3-3: Fastest Growing Interventional Cardiology Markets By Country, Europe, 2005 - 2015
    • Chart 3-4: Leading Competitors, Market For Interventional Cardiology, Europe, 2008
  • Country Profiles
    • Chart 5-1: German Price Index, Des Penetration, Population, Gdp Per Capita, And Pci Penetration Rate, 2008
    • Chart 5-2: French Price Index, Des Penetration, Population, Gdp Per Capita, And Pci Penetration Rate, 2008
    • Chart 5-3: The U.K. Price Index, Des Penetration, Population, Gdp Per Capita, And Pci Penetration Rate, 2008
    • Chart 5-4: Italian Price Index, Des Penetration, Population, Gdp Per Capita, And Pci Penetration Rate, 2008
    • Chart 5-5: Spanish Price Index, Des Penetration, Population, Gdp Per Capita, And Pci Penetration Rate, 2008
    • Chart 5-6: Beneluxian Price Index, Des Penetration, Population, Gdp Per Capita, And Pci Penetration Rate, 2008
    • Chart 5-7: Scandinavian Price Index, Des Penetration, Population, Gdp Per Capita, And Pci Penetration Rate, 2008
    • Chart 5-8: Portuguese Price Index, Des Penetration, Population, Gdp Per Capita, And Pci Penetration Rate, 2008
    • Chart 5-9: Austrian Price Index, Des Penetration, Population, Gdp Per Capita, And Pci Penetration Rate, 2008
    • Chart 5-10: Swiss Price Index, Des Penetration, Population, Gdp Per Capita, And Pci Penetration Rate, 2008
  • Bare-Metal And Drug-Eluting Stents
    • Chart 6-1: Market For Coronary Stents By Type, Europe, 2005 - 2015 (
    • Chart 6-2: Penetration Rate For Coronary Stents By Type, Units Sold, Europe, 2005 - 2015
    • Chart 6-3: Market For Bare-Metal Stents, Europe, 2005 - 2015 (
    • Chart 6-4: Leading Competitors, Market For Bare-Metal Stents, Europe, 2008
    • Chart 6-5: Market For Drug-Eluting Stents, Europe, 2005 - 2015 (
    • Chart 6-6: Leading Competitors, Market For Drug-Eluting Stents, Europe, 2008
    • Chart 6-7: Penetration Rate For Bioabsorbable Stents, Europe, 2010 - 2015
    • Chart 6-8: Penetration Rate For Bifurcated Stents, Europe, 2010 - 2015
  • Abbreviations